The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

HCP Inc

NYSE: HCP
Last

(U.S.) $40.60

Today's change+0.31 +0.77%
Updated May 1 4:04 PM EDT. Delayed by at least 15 minutes.
 

HCP Inc

NYSE: HCP
Last

(U.S.) $40.60

Today's change+0.31 +0.77%
Updated May 1 4:04 PM EDT. Delayed by at least 15 minutes.

HCP Inc up (U.S.)$0.31

HCP Inc closed up Friday by (U.S.)$0.31 or 0.77% to (U.S.)$40.60. Over the last five days, shares have lost 4.36% and sit 3.20% above their 52-week low. This security has underperformed the S&P 500 by 15.42% during the last year.

Key company metrics

  • Open(U.S.) $40.26
  • Previous close(U.S.) $40.29
  • High(U.S.) $40.93
  • Low(U.S.) $40.20
  • Bid / Ask-- / --
  • YTD % change-7.79%
  • Volume3,400,995
  • Average volume (10-day)3,167,482
  • Average volume (1-month)3,168,618
  • Average volume (3-month)3,675,536
  • 52-week range(U.S.) $39.34 to (U.S.) $49.61
  • Beta0.41
  • Trailing P/E20.94×
  • P/E 1 year forward20.16×
  • Forward PEG6.72×
  • Indicated annual dividend(U.S.) $2.26
  • Dividend yield5.57%
  • Trailing EPS(U.S.) $1.94
Updated May 1 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+39.41%

Based on its net profit margin of 39.41%, HCP Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.76%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue604597536530
Total other revenue--------
Total revenue604597536530
Gross profit473497457454
Total cost of revenue1301007976
Total operating expense271248221204
Selling / general / administrative20252921
Research & development--------
Depreciation / amortization116123113107
Interest expense (income), net operating--------
Unusual expense (income)4------
Other operating expenses, total--------
Operating income333349315326
Interest income (expense), net non-operating-115-111-107-107
Gain (loss) on sale of assets3------
Other--------
Income before tax223241209221
Income after tax225241208219
Income tax, total-3011
Net income197248219259
Total adjustments to net income000-1
Net income before extra. items197248219231
Minority interest-3-3-3-3
Equity in affiliates-26101515
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items196247218229
Inc. avail. to common incl. extra. items196247218258
Diluted net income196247218258
Dilution adjustment0--0--
Diluted weighted average shares460459459458
Diluted EPS excluding extraordinary itemsvalue per share0.430.540.480.50
Dividends per sharevalue per share0.550.550.550.55
Diluted normalized EPSvalue per share0.430.470.490.50